Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Optimal Hypertension Regimens (AIMHY-INFORM)
NCT02847338Phase 4Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Nov 2016
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amlodipine, lisinopril, chlorthalidone, amiloride in hypertension (HTN), sponsored by Cambridge University Hospitals NHS Foundation Trust. Started Nov 2016; status: completed.
02
Drugs
amlodipinelisinoprilchlorthalidoneamiloride
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02847338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02847338.